To further determine the protein expression of SPRY2 in fibroblasts of breast cancer, we performed immunohistochemical (IHC) analysis in a human breast cancer tissue microarray (TAM) from 132 cases of breast cancer patients. Here, SPRY2 is linked to breast cancer.